by vittorio | Mar 11, 2019 |
MyoGene Bio is developing cutting edge therapeutics for muscle diseases, starting with a gene editing therapy for Duchenne muscular dystrophy. Market:Duchenne muscular dystrophy (DMD) is a severe, progressive muscle wasting disorder that affects approximately 1 in...
by vittorio | Mar 11, 2019 |
Myst Therapeutics, Inc. is developing novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to destroy solid tumor cancer cells. Market:Over 400,000 Americans die from cancer every year, with roughly 10% being blood cancers...
by emilybrown | Mar 8, 2019
Vivibaba specializes in protein delivery and advanced formulation of protein therapeutics. Market:Compared with small molecular drugs, protein therapeutics generally show higher specificity and potency. Broad adaption of protein therapeutics, however, has been limited...
by emilybrown | Jan 3, 2019
EarlyDx is devoted to providing accurate, affordable, and non-invasive methods for early cancer detection and location. Market:Cancer patients who get treated at an early stage survive much longer. For example, a few tests (such as Pap and HPV tests for cervical...
Recent Comments